Announcement and press conference by the President of the Nation, Alberto Fernández, and the Minister of Health of the Nation, Ginés González García, in the Conference Room, Casa Rosada.

Argentina Alberto Fernández · President of Argentina

10 December 2020 · Announcement and press conference · Casa Rosada

Context
Fernández announced Argentina's contract with Russia's Sovereign Fund for Sputnik V vaccines at a press conference at Casa Rosada on December 10, 2020.
Main themes
COVID-19 vaccination contract, Sputnik V Russian vaccine, vaccine delivery timeline, priority vaccination groups, ANMAT approval process, AstraZeneca and COVAX agreements, pandemic persistence and second wave warning, herd immunity, Argentina public health strategy, gratitude to Russia and President Putin
Duration
~39 min
90th percentile
Words
4,738
90th percentile
Sentences
177
86th percentile
Readability
52
67th percentile
Grade
12.7
53rd percentile
Syntax
3.17
69th percentile
Vocabulary
2.02
13th percentile

Translated from Spanish

This is an interview, press conference or exchange with other speakers. It is split into sentences and counted in the corpus, but its sentences are not tagged on the twelve indices.

177 sentences in 30 paragraphs

PRESIDENT.- Good day to everyone, it is a pleasure to have you here.

What have we come for? We have come to inform you that yesterday we signed the contract with the Sovereign Fund of the Russian Federation, which guarantees us the provision of Russian vaccines for Argentina. This is the third contract that Argentina has signed: the first was with AstraZeneca and the University of Oxford, the second was with COVAX, which is a body, an organization created by the United Nations, and the third is precisely the one we have signed with the Sovereign Fund of the Russian Federation.

What does this contract say? This contract states that we will have enough doses to vaccinate ten million Argentines between January and February. The delivery times are estimated to have the first shipment of around 600,000 doses, to vaccinate 300,000 people before the end of the year, that during January we will have enough doses to vaccinate 5 million people, and that in February the rest of the necessary doses will be completed to achieve the vaccination of the 10 million people we are anticipating.

The contract also has something more, which is very important for us, it has a preference in favor of Argentina to access the necessary doses to vaccinate 5 million more people during the month of March. That is to say, Argentina could during the month of January make use of that preference and have ten million more doses in March, to vaccinate 5 million more Argentines during the month of March. Why did we make this provision? In case the other vaccines, with which we also have contracts, delay their arrival in the country. For us, this is very important; it is clear that we have to organize all the logistics of sending to Argentina, it is complicated logistics. We are talking about many doses that have to come from the other side of the world, and we are also organizing everything necessary for the vaccine to have the final approval of our control body, which is ANMAT. To that end, next week officials from the national government and officials from ANMAT are traveling precisely to verify on-site all the doubts that need to be clarified regarding the production conditions and the quality of the vaccine, which we are very convinced is very important what we have achieved and what we can count on.

I want to emphasize my gratitude to the Russian Sovereign Fund for the diligent and rapid way in which they were able to negotiate this agreement with us, which I repeat is very important for Argentina, it allows us to access the vaccine at the same time as the central world. I especially want to thank President Putin, because he personally took care of helping to make this happen. And what I want is to call for reflection to all Argentines, which is that we understand that these vaccines we are receiving will allow us to vaccinate at-risk people before anyone else. That is, health personnel, Armed Forces and Security personnel, teachers, people over 60 years old, and people between 18 and 60 years old who have prevalent diseases, which total around 13 million people.

Now, what we have to understand is that the vaccine has not resolved the pandemic, and that the pandemic persists, that the pandemic is among us and we must pay particular attention to what is happening in neighboring countries and what is happening in Europe. And while we trust that the second wave will arrive as it did in Europe in the fall, we have not resolved the problem. Therefore, all that social relaxation that we see, we ask for a call to reflection from everyone because, in the meantime, the virus continues to circulate and the risk continues to increase, and we are very far from having resolved that problem. It is true, with the vaccine we will give immunity to those who are most at risk. If we take into account that the median age of death is 74 years, it is clear that we will help ensure that all those people do not run the risk of getting sick and dying, but in the meantime we must keep in mind that we must continue to take care of ourselves, okay?

For us, the news of the vaccine is great, it is a very important step, we are not anticipating that vaccination will end in March, in March vaccination will continue with other vaccines that we have purchased. The AstraZeneca and Oxford vaccine if production finally gets underway and the COVAX vaccine, which is that pool created by the United Nations, where we all pre-purchase the vaccine, so that the day the vaccines are available, they distribute them among the countries that purchased them. Being able to count on a contract that already tells us exactly when the vaccines will arrive in Argentina is a great advance for us and a great relief. And it is something that the National Government has worked hard to guarantee that, in the summer, we can give the vaccine to those who need it most, minimize the lethality of the disease, and well, take an important step in favor of herd immunity that is so much talked about, because we would have a quarter of Argentina already vaccinated specifically, but this does not mean that we have resolved the problem. That is why I call everyone's attention, I ask everyone to take extra care, I ask everyone not to feel liberated from the pandemic, because we have not achieved that yet.

Ginés, do you want to add something?

GONZÁLEZ GARCÍA.- No, President. Nothing. I think we are working intensively, obviously the challenge is always from the factory (audio jump) of the people, and that challenge is not simple, as the President said. First, it has a huge logistical challenge in vaccines, which as you know have unusual storage temperatures for what the network is. From the loading point of the plane that brings it, to the distribution throughout the country, to reach the vaccination centers. We have been working on that program for quite some time with all the provinces. At this moment, for example, there are officials from the Ministry of Health in all Argentine provinces, who are working together with local authorities and local technicians in the programming of vaccination. Never in history has there been such a massive and extensive vaccination. That is to say, think that we supply 40 million doses of all vaccines per year, and this alone will be 60 million in the first half. So, you realize that it is a logistical, operational, programming, and vaccination challenge in itself, truly of an unprecedented magnitude. So we are working very hard on that and I think we are also gaining time. In the same way that, as the President said, all the phases that have to be approved for emergency, the only vaccine that has been approved in the world with emergency approval is the one that the United Kingdom did a few days ago. I believe that this week, or before the end of this month, there will be several of that type. And we will work to improve the times it takes, with this technical team that is going directly to Russia, and at the same time also naturally working intensively to have availability as soon as possible, but I reaffirm what the President said. In reality, this has not passed, I believe we are still going down, we are very happy, but we are the only country in the Southern Cone, at least in the peripheral sense, that is working, all the others are at increasing risk these days, in the middle of summer. So, the idea that this has been resolved is not there, neither because of the climate, nor because there is still no vaccine. And even when the vaccine is available, until we achieve the necessary levels of immunity in a population to reduce the circulation of the virus, several months will pass. So, we will initially reduce mortality, with this that I mentioned about priorities, but we will not reduce the spread of the virus. That means we have to continue with the behavior. So, in this sense, I reaffirm a bit what the President said, which is the concern and occupation of the entire Government.

JOURNALIST.- First, I would like to ask for some clarifications regarding the announcement you made about the Russian vaccine, the President said it will come from faraway places, that is, it will be produced in Russia, it will be produced in other countries, it is not clear exactly where the production site is. I mean, to give the population assurance that it will indeed arrive in the times being announced. On the other hand, I would like to ask about Pfizer, does this mean that there will be no contract with the Pfizer company? Thank you.

GONZÁLEZ GARCÍA.- The first question: Obviously there is uncertainty worldwide and today there is a strong bottleneck in production. Pfizer announced that it is reduced to half of what it thought it would produce this year. So, all this is a mechanism we are going through almost daily. As we have had the safeguard of talking with several suppliers, because not all of them, including those named by the President, we have been talking with the Chinese for a long time, with the Sinopharm vaccine, we are with Sinovac, which is another Chinese one, also talking with the Butantan Institute. That is to say, we have a wide margin. Regarding Pfizer, we have asked Pfizer with the condition that it was first, because otherwise the price of Pfizer was very different from other prices. So, naturally, it was the priority and that is why we asked for vaccines for December, January, and February. At first, Pfizer said it had the possibility of delivering some doses in December and the rest of the 3 million, which we are discussing, between January and February. Unfortunately, despite the fact that they asked us for a safeguard with a law that the Argentine Congress passed, we have still not been able to sign the contract. As a consequence, we do not know exactly what it is, but they say that the headquarters, that this and that. We continue to talk, but we really have not been able to sign the contract, despite the enormous will of the Argentine Government. Do not forget that Pfizer was the first to receive the President himself when he did the clinical trial, the clinical trial has already finished in Argentina, 6,000 volunteers. And clearly, I say again, on the one hand, I have the suspicion, but I cannot confirm it, because they have not told me so, that there is a problem of availability. For which they do not dare to sign a contract that had to do with a timeline. I add to what the President said that the only bidder that offered security, and not only security from a nominal point of view but contractual, regarding delivery, is the Russian bidder, because if it does not deliver under those terms, the contract is not fulfilled. The vaccine is produced in many places, technology is transferred, I understand that the Russian company is also looking to transfer technology, but it has not been concretized yet. The first ones I understand will come from Russia, but the large-scale production, as almost everything, is done in Asia; it will be, according to what they told us, Korea or India.

PRESIDENT.- Russia has proposed, as you say, several production sites, one is Korea, another is India, another is Bangladesh. We do not know exactly where they will supply us with the Russian-origin vaccines and that is what we are, the commitment has been made by the bidder and they will tell us where we need to go to get the vaccines.

JOURNALIST.- President, once the first stage of vaccination is completed with this number of doses that will come, when would it be fulfilled for the rest of the population, not the at-risk groups and what you just mentioned? And to Minister Ginés, if they are going to do any campaign or something for people who are still unsure about getting vaccinated, distrustful, or directly belong to some anti-vaccine movement.

PRESIDENT.- What we are really trying to do is to vaccinate all Argentines who need to be vaccinated, that is why we -as Ginés just explained- have signed other contracts and we are also trying to advance with other bidders, for the days after March. The idea is that we will have, because the impression that the scientific community has is that the world will have to live with this virus for many years. And therefore, I imagine it must be something similar to what is experienced with the flu vaccine that you have to get the dose annually to avoid it. So, we will have, after March, a vaccination calendar that will continue for all those who want to be vaccinated and with which we want to give immunity to as many Argentines as possible. For that, there are the AstraZeneca vaccines, for that, there are the COVAX vaccines, for that, there are the possible Chinese vaccines and eventually more Russian vaccines; that is what they are for. I want to say that we have analyzed the Russian vaccine a lot, here in Argentina there are some who sow many doubts about the scientific quality of Russia, but the institute where the vaccine was developed is an institute that has several Nobel laureates among its scientists. And I, to dispel any doubts, when that vaccine is here, the first one to get vaccinated will be me, because I have no doubt about the quality of the vaccine. That, clearly, we will do immediately after ANMAT gives the pertinent approval, right? Because there we must respect Argentine safety standards in this matter, but I have no doubt about its quality.

JOURNALIST.- (inaudible)

PRESIDENT.- Yes, that is why I said that I will get vaccinated before anyone else so that no one is afraid.

GONZÁLEZ GARCÍA.- I was going to say the second. Nothing, what the President said. Regarding the campaign you mentioned, the safety of the vaccine will be somewhat determined by its own evolution. We are going to implement a pharmacovigilance system for each vaccinated individual, which is done in the first year, as is required for any new product, and we are prepared for that at ANMAT. And the campaign has to be carried out, which will be much more emphasized, working precisely with the care of each one of us. That is a better vaccine than the vaccine itself, in these first months, right?

JOURNALIST.- I wanted to ask the Minister, I understand that the Russian vaccine comes in two types of formulations, if both will be acquired and if the distribution will be federal. And President, well, I cannot let today’s date pass without asking you for some assessment of this first year of management. Thank you very much.

GONZÁLEZ GARCÍA.- Yes, the Russian vaccine, like all the vaccines we are working on, has two doses, and the doses have an interval of 21 to 28 days, which is a double challenge. We have purchased 10 million doses, meaning 20 million vaccine vials, but that covers 10 million people. That is the volume, and I think that answers what you asked me, right? It’s a somewhat technical detail, but I’ll share it. There is one type of vaccine, the Russian one, the Astra one, that uses a vector and uses a virus as a vector. That is to say, it’s like, for example, a vector is like the mosquito for dengue. This virus carries the protein that generates the antibody. That vector, in the Russian vaccine, is from a human virus and they are two different viruses. Supposedly, this gives it greater capacity and coverage. But, in any case, I reiterate, as the President rightly said, all of this is a process that takes time and we did not start now; since the beginning of November, the Russian vaccine has been sending information, Astra has been sending information since the beginning of October. Because as the information is produced, they send it sequentially almost in real time, each of those who are in phase 3, the clinical trial phase. So we are already working, plus all the stockpiling that means the things that technically need to be accelerated, because obviously it is a fundamental variable in the sense that what we want is to reduce mortality as the primary objective. And for that, having the vaccine ready is essential.

PRESIDENT.- The vaccine, just to add, is a vaccine that is given in two doses and so far shows a high level of effectiveness, over 90 percent. Only the first dose is the one that provides the greatest amount of antibodies, and that has already been quite scientifically verified. The first dose is given, and the second dose should be given starting from day 21, meaning it does not have to be given exactly on day 21, but from day 21 onwards it can be given at any time, and there is no time limit either, because in truth what the second dose does is add more antibodies, as Ginés rightly said, through another vector, to enhance what the first vector of the first dose has already developed, okay? I believe we have done an unusual job in politics; the unusual thing is having governed the unknown. This morning I spoke with Axel and talked about that idea. The experience of others has served us little because no one has had to face the challenge of the unknown, of not knowing where they will be attacked, where the management idea will become complicated. Knowing that we were also coming from a particularly ruinous scenario, where public health had been left absolutely unprotected. In March, all our objectives changed, but they changed in the sense that we had to prioritize other things. Our objectives were, are, and will continue to be the same: to produce and create jobs, and above all to assist those who are worst off. If we had not done everything we did this year, the Catholic University says, indigence in Argentina would not be 10 percent, it would be 27 percent, and poverty would not be 44 percent but would be ten points higher. And that was the result of the actions of a government that did not turn a blind eye to the needs that millions of Argentines were experiencing. We have been able to, with all of that, somewhat restore an economy that was completely deranged by debt, and we have been able in that context to carry out something that the world marvels at, which is having achieved a particularly advantageous agreement with creditors for Argentina. I want to believe that today, ironically, December 10, Ginés signed the contract with the Russian federation yesterday, that today, precisely when we mark one year, we are putting a turning point with the vaccine. And that turning point will start to allow us to see how we approach the future differently, knowing that in some way we are starting to control the risk of the pandemic. And the irony is that it happens on December 10, exactly one year later. I believe we have all the opportunities next year to do things right together, united, and to be able to lift the country and get those who need it most out of the state of prostration they are in, which is, in my opinion, what should concern us the most. We have a huge advantage for those who talk about adjustment; next year Argentina will be freed from paying 12.5 billion dollars in interest, and those resources we can channel into production, into jobs, and into assisting those who are having the worst time. So I feel that with a lot of effort we have done a great job, which we were able to do because millions of Argentines supported us, despite some who did not, and that moving forward we have every possibility to start changing reality. As I always say, I want to start building another normality, not the normality we lived in, the normality in which one day a virus appeared and left us exposed that we had neither a Ministry of Health, nor hospitals, nor ventilators, nor therapists. I do not want to return to that reality; I want another reality, and that is what I invite Argentines to start building another normality, that normality that is quite evidently abnormal.

JOURNALIST.- Continuing with this assessment, you had a university exam, right? On one hand, I want to ask you what grade you would give this first year of government. And on the other hand, we cannot fail to ask you during this time of assessment, yesterday there was an assessment from the Vice President, and she spoke about Justice; do you share the Vice President's view of Justice? She spoke of extortion, spoke of persecution that continues to this day. What is your view on this?

PRESIDENT.- I was taking exams yesterday, but in truth, the ones who have to give the grade are the citizens, not me; I do not self-grade. What I believe is that what Cristina said yesterday is a wake-up call for everyone, because the Justice system, as I have been saying for many years, is not functioning well in Argentina, it is not functioning well, and it is not about preserving the rights of someone who may be subjected to Justice. The point that Cristina made yesterday is much deeper, and I must confess that I share much of what she has raised there, because it is an objective view of what is happening in Argentina regarding Justice, which we have not managed to resolve because Justice also has a corporate logic that makes it impermeable to any possibility of change, and that needs to be changed, because it is clearly not functioning. But, I repeat, let’s not talk about the case of someone in particular. A few days ago, I saw that a trial, the trial for Río Tercero, twenty-some years later, was brought to oral trial; is that how Justice functions well? I wouldn’t want to ask about the trials of workers who have a case in labor court for dismissals or the trials for damages in civil court, or the trials that take years for bankruptcies in commercial court; I don’t want to dwell on that. Justice really has to, at some point, accept that we must take care of Justice. The Legislative and Executive Powers, the political powers in these years of democracy, often do not review and often change things, many times. I think it would be very good for the Judicial Power to use that corporate vocation to improve itself, to improve itself, because it is functioning poorly, definitely. And with this, it is not an act of interference in Justice, because judges are part of the Republic, and as part of the Republic, they are subject to public criticism. And it is very obvious that the judicial system in Argentina is functioning poorly, definitely.

JOURNALIST.- (INAUDIBLE)

PRESIDENT.- Well, I am trying to at least start with the first one, right? That the Chamber of Deputies dignifies itself to approve the Reform in the Federal Jurisdiction, which is something that serves many, because when you go to Rosario and talk to them about the problems of drug trafficking in Rosario and the lack of prosecutors and more federal judges, and chambers that resolve things quickly, we are talking about that same Federal Justice. In the interior of the country, not all Federal Justice, the only problem that Federal Justice has is not only the corruption of a public official; they understand that all cases of organized crime pass through Federal Justice. And that we must resolve, that is functioning poorly and is one of the most severe problems we have. That is why I also want to draw everyone's attention to this point, because I am tired of reading that the Commission we had made of jurists, which I will receive now, was a commission without any academics, judges. Each one expressed what they wanted; you read the conclusions and realize that each one expressed what they believed was best. And the truth is that it is a wonderful job they have offered, wonderful. The truth is that all I want is to have a Justice that works with dignified judges; that is all I want.

JOURNALIST.- In this regard, how can Justice function correctly in Argentina? And related to the vaccine, you just mentioned that the problem has not yet passed, that the virus continues to circulate. The holidays are coming, summer is coming; will there be any restrictions on movement to prevent Argentines from moving around the territory and thus circulating the virus? Thank you.

PRESIDENT.- I’ll start with the end. Worldwide, there is a serious problem in restricting people's movement, because obviously we have lived through a very singular year where people were overwhelmed by the limitations, and this problem occurs everywhere in the world, in all latitudes. That is why one is left only to try to convince and draw individual attention to the risk that is being run. I think we will have to operate with that logic, but it is very important that they understand the risk that is being run, because nothing is resolved yet. And regarding Justice, I think it is a topic we must tackle together; I sent the issue to Congress for Congress to debate, not to stop it. The Senate addressed it, it came out quickly, it reached the Chamber of Deputies, and it has been stalled for months, and in truth what we need is for the deputies to debate it. If the opposition has something to propose, to correct, let them say it, let them propose it, and we will correct it. We have to start working together because this Justice does not serve anyone, it really does not serve anyone, really.

JOURNALIST.- The question relates to what you were announcing regarding why the vaccine documentation has not yet reached ANMAT and also regarding the logistics plan, if you will perhaps use or ask for help from the private sector for its distribution.

PRESIDENT.- No, I want to clarify that the documentation has arrived and that documentation has been arriving for some time, and we have been in contact with Russia for a while. As Ginés said, everyone is doing that; AstraZeneca is doing that, Pfizer is doing that, everyone is doing that. What we did, and what we are going to do now, is that ANMAT technicians can go on-site and see exactly the entire development of the research, see where it is produced, how it is produced. What ANMAT needs to know, I am a lawyer, maybe you are in better conditions than I am, but what technically needs to be known to approve a vaccine. And it is clear that Russia has its own rules of operation and approval for this type of product, which do not exactly coincide with those of the West. And so, well, what we are trying to see is how we can make them compatible; it is not that they do less or do more, they have different logics, but the information is there, it needs to be sought, it needs to be verified, and what ANMAT must provide us is certainty that what we are buying is the quality that Argentines can receive. But that information has been received for some time, okay?

JOURNALIST.- (INAUDIBLE) you just mentioned 600,000 doses that will be for 300,000 vaccinations; will they be in Buenos Aires only or throughout the country?

PRESIDENT.- No, no, we will distribute it throughout the country, and we will do it surely in proportion to the number of inhabitants in each place, but everyone will receive what they need to receive. No, no. Look, with what I believe in federal Argentina, I would never leave the interior unprotected. Thank you very much to all. Thank you.